Medicine, Epidemiology & Public Health
Division Head, Pediatric Cardiology
Director of the Pediatric & Congenital Heart Program
110 S. Paca Street (Paca/Pratt), 7th floor
Education and Training
B.A., 1984, Boston University, College of Liberal Arts, Psychology
M.S., 1987, Georgetown University, Biostatistics & Epidemiology
M.D., 1992, University of Maryland School of Medicine
Ph.D., 1992, University of Maryland Graduate School, Epidemiology
Geoffrey L. Rosenthal, M.D., PhD., a nationally-known pediatric cardiologist, is professor of the Department of Pediatrics at the University of Maryland School of Medicine. Dr. Rosenthal is the Director of the Children's Heart Program at the University of Maryland Children's Hospital.
Dr. Rosenthal came to the University of Maryland from the Cleveland Clinic in July 2009. At Cleveland Clinic, he served as Director of Inpatient Medicine for Pediatric Cardiovascular Services and Director of Pediatric Cardiovascular Research.
Dr. Rosenthal earned his undergraduate degree in psychology from Boston University, a master's degree in biostatistics & epidemiology from Georgetown University, a medical degree from the University of Maryland School of Medicine, and a doctor of philosophy degree in epidemiology from the University of Maryland Graduate School.
Dr. Rosenthal completed his pediatric residency, neonatology chief residency, pediatric cardiology fellowship, and perioperative fellowship in pediatric cardiology at Baylor College of Medicine/Texas Children's Hospital. Dr. Rosenthal is certified by the National Board of Medical Examiners and the American Board of Pediatrics in General Pediatrics and Pediatric Cardiology. Dr. Rosenthal is also certified in Adult Congenital Heart Disease through the American Board of Internal Medicine.
Dr. Rosenthal serves on the Executive Committee for the Section of Cardiology and Cardiac Surgery of the American Academy of Pediatrics. He is a founding member and current task force member of the National Pediatric Cardiology Quality Improvement Collaborative of the Joint Council on Congenital Heart Disease. Dr. Rosenthal is also a member of the National Program to Reduce Cardiovascular Risk Coordinating Committee of the National Heart, Lung, and Blood Institute, representing the American Academy of Pediatrics. Dr. Rosenthal served as the Chair of the Pediatric Advisory Committee to the U.S. Food and Drug Administration until 2012 and has been a member since 2007. Dr. Rosenthal also served as the Co-Chair of the Congenital Heart Public Health Consortium and the Co-Chair of the Quality Metrics Working Group of the American College of Cardiology until 2014.
Pediatric cardiac research, medical education, General pediatric cardiology, pediatric cardiac intensive care and adult congenital heart disease
Anderson JB, Beekman RH, Kugler JD, Rosenthal GL. Jenkins KJ, Klitzner TS, Martin GR, Neish SR, Darbie L, King E, Lannon C. Use of a Learning Network to Improve Variation In Interstage Weight Gain After the Norwood Operation. National Pediatric Cardiology Quality Improvement Collaborative. Congenit Heart Dis. 2014 Nov-Dec; 9(6):512-20. Doi: 10.1111/chd.12232.Epub 2014 Oct 31
Baker-Smith CM, Goldberg SW, Rosenthal GL. Predictors of Prolonged Hospital Length Of Stay Following Stage II Palliation of Hypoplastic Left Heart Syndrome (and Variants): Analysis of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) Database. Pediatr Cardiol. 2015 June; 36(8):1630-41.
Chaves AH, Sebastian J, Hoopes S, Rosenthal GL. The Effect of a Quality Improvement Intervention on Variability of Measurements of Left Ventricular Dimensions in a Pediatric Echocardiography Laboratory. 2015 July; 10(4):340-5. doi: 10.1111/chd.12258.Epub 2015 March 24
Anderson JB, Beekman RH 3rd, Kugler JD, Rosenthal GL, Jenkins KJ, Klitzner TS, Martin GR, Neish SR, Brown DW, Mangeot C, King E, Peterson, LE, Provost L Lannon C; National Pediatric Cardiology Quality Improvement Collaborative. Improvement in Interstage Survival in a National Pediatric Cardiology Learning Network. Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):428-436. Doi:10.1161/CIRCOUTCOMES.115001956.Epub 2015 Jun 9
Cope JU, Rosenthal GL, Weinel P, Odegaard A, Murphy DM; FDA Safety Reviews on Drugs, Biologics and Vaccines: 2007-2013. Pediatrics. 2015 Dec: 136(6): 1125-31. doi: 10.1542/preds.2015-0469
2010 Baltimore’s Top Doctors 2010 – Baltimore Magazine
2012 Commitment to Excellence Award, “The Ripple Story,” University of Maryland Medical Center
2012 Baltimore’s Top Doctors 2012 – Baltimore Magazine
2013 Baltimore’s Top Doctors 2013 – Baltimore Magazine
2013 Best Doctors in America 2013 – Best Doctors Publication
2014 Best Doctors in America 2014 - Best Doctors Publication
2015 Baltimore’s Top Doctors 2015- Baltimore Magazine
2016 Baltimore’s Top Doctors 2016- Baltimore Magazine
University of Washington
1999 – 2001 Principal Investigator, A Study of the Safety, Tolerance and Efficacy of Palivizumab (MEDI-493, Synagis) for Prophylaxis of Respiratory Syncytial Virus in Children with Congenital Heart Disease. Medimmune, Inc.
2000 – 2001 Principal Investigator, Prophylactic Use of Primacor in Pediatric Patients at High Risk of Developing Low Cardiac Output Syndrome Following Surgery. Sanofi-Synthelabo, Inc.E IV 7867, PRIMACORP)
2001 Principal Investigator, A Phase 2 Study of the Safety and Efficacy of TP10 (sCR1) in the Prevention of Post Cardiopulmonary Bypass Syndromes in Infants Aged One Year and Less Undergoing Cardiac Surgery Including Cardiopulmonary Bypass (TP10-PCS-004). Avant Immunotherapeutics, Inc.
2001 Co-Investigator, Principal Investigator: Troy Johnston, M.D. Study of Blood Pressure Reduction with Fosinopril in Children and Adolescents (CV 118-028). Bristol-Myers Squibb
2001 Co-Investigator, Principal Investigator: Michael A. Portman, M.D. Triostat in Children during CPB (IND55367). FDA-OPD-01
2001 Co-Investigator, Principal Investigator: Thomas K. Jones, M.D. VenPro: Contegra Pulmonary Valved Conduit (9202-99C). VenPro Corporation
Cleveland Clinic Foundation
2/2003 – 2/2004 Principal Investigator, Multi center placebo controlled 8 month study of the effect of twice daily Carvedilol in children with heart failure due to systemic ventricular systolic dysfunction
12/2003 – 12/2004 Co-Investigator, Analysis of nitric oxide levels in the lungs of children after cavopulmonary anastomosis
8/2004 – 8/2005 Principal Investigator, Registry: Pediatric Cardiomyopathy Registry: A Multicenter Registry/Database (NIH/Cardiomyopathy Registry)
7/2004 – 7/2005 Principal Investigator. Surgical outcome among patients with 22q11 deletion
2/2004 – 2/2009 Statistical Support during Project Development, Principal Investigator: Brian Duncan, M.D. The “PediPump”, A Versatile, Implantable Pediatric Ventricular Assist Device. NIH, Contract No. BAA NHLB1-HV-04-01
7/2005 – 6/2006 Principal Investigator, Chart Review: Outcomes of cardiac surgery for adults with congenital heart disease
6/2005 – 6/2006 Principal Investigator, Chart Review: ECMO Oxygenator Durability
10/2005 – 1/2006 Principal Investigator, A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children with Hemodynamically Significant Congenital Heart Disease (MedImmune, Inc.)
University of Maryland
7/2014 - 6/2015 Co-Investigator, NIMH 16-14681G/M006400091, "Center for Excellence on Early Intervention for Serious Mental Illness
1/2014 - 6/2016 Co-Investigator, DHMH OPASS #14-13848G, Research and Evaluation for the Maryland Center of Excellence for Problem Gambling
Federal Government & Public Advisory Committee Memberships
2006-present Steering Committee Member, National Pediatric Cardiology Quality Improvement Collaborative – a Joint
Council of Congenital Heart Disease initiative
2007-2009 Member, Pediatric Advisory Committee of the U.S. Food and Drug Administration (term 7/2007 – 6/2011)
2009-present Chair, Pediatric Advisory Committee of the U.S. Food and Drug Administration
2009-present Co-Chair, Quality Metrics Working Group Steering Committee, American College of Cardiology (term 2/2009- 3/2013)
2009-present Co-Chair, Congenital Heart Public Health Consortium (term 7/2009-7/2013)
2011-present Member, National Program to Reduce Cardiovascular Risk Coordinating Committee of the National Heart, Lung, and Blood Institute, representing the American Academy of Pediatrics